Market Place
Sourcing Support
Axsome Presents Data from Multiple Programs at Sleep Europe 2024
24 Sep 2024 //
GLOBENEWSWIRE
Axsome Settles Sunosi Patent Litigation With Sandoz
21 Aug 2024 //
GLOBENEWSWIRE
Axsome Initiates Ph 3 Trial of Solriamfetol for Binge Eating Disorder
01 Apr 2024 //
GLOBENEWSWIRE
Axsome Hosts Solriamfetol Investor Event with Expert Thought Leaders Today
07 Dec 2023 //
GLOBENEWSWIRE
FDA Confirms Paragraph IV Patent Litigation for Solriamfetol Hydrochloride
08 Aug 2023 //
FDA
Axsome Therapeutics Initiates FOCUS Phase 3 Trial of Solriamfetol
07 Jul 2023 //
GLOBENEWSWIRE
Axsome to Present 5 Abstracts Including New Data +ve SHARP Study of SUNOSIÂ
21 Apr 2023 //
GLOBENEWSWIRE
Axsome Enters into Agreement with Pharmanovia to Develop solriamfetol
22 Feb 2023 //
GLOBENEWSWIRE
Axsome Therapeutics Announces Sunosi® (Solriamfetol) Meets Primary Endpoint
03 Oct 2022 //
GLOBENEWSWIRE
Jazz Pharmaceuticals Completes U.S. Divestiture of Sunosi to Axsome Therapeutics
09 May 2022 //
PRNEWSWIRE
Axsome Therapeutics Completes U.S. Acquisition of Sunosi
09 May 2022 //
PRNEWSWIRE
Jazz Pharma Announces Agreement to Divest Sunosi to Axsome Therapeutics
28 Mar 2022 //
PRNEWSWIRE
Solriamfetol Effective in Maintenance of Sleep Apnoea-Related Daytime Sleepiness
26 Oct 2020 //
FIRSTWORDPHARMA
Solriamfetol Associated With Improved Work Productivity in Patients
13 Oct 2020 //
FIRSTWORDPHARMA
Jazz Pharma partners with Durbin on global EAP for narcolepsy drug
24 Sep 2020 //
PHARMALETTER
Jazz Pharmaceuticals to Present New Data on Xywav™ Oral Solution
26 Aug 2020 //
PRNEWSWIRE
Jazz Pharma Receives EU Marketing Authorisation for Sunosi for Sleep Apnea
21 Jan 2020 //
PR NEWS WIRE
SK Biopharmaceuticals CEO promises new drug every other year
20 Jan 2020 //
THE KORES HERALD
Jazz Pharma`s sleep disorder drug gets European panel backing
16 Nov 2019 //
REUTERS
Ready, aim, launch: Jazz targets docs, consumers with branded Sunosi campaigns
08 Jul 2019 //
FIERCE PHARMA
Jazz plans early July launch for sleepiness med Sunosi after DEA scheduling
18 Jun 2019 //
FIERCE PHARMA
Jazz Pharmaceutical Announces FDA Approval of Sunosi™ (solriamfetol) for OSA
20 Mar 2019 //
PR NEWSWIRE
Jazz hiring 100-plus sales reps for new narcolepsy and AML launches
20 Aug 2018 //
FIERCE PHARMA
Verily and ResMed Team Up on Joint Venture to Study Sleep Apnea
13 Jul 2018 //
BIOSPACE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.